The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.

Columnist Candace Semien considers the rules, both written and unspoken, about how to maintain a healthy patient-doctor relationship.

The focus of this year’s awareness month is “Make Lupus Visible” — given that the chronic condition is often invisible to others. For World Lupus Day on May 10, the World Lupus Federation, a global ...

Columnist Marisa Zeppieri reminds us that autoimmune disease is not a moral failure, and we should replace self-blame with self-love.

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for lupus nephritis.

Columnist Candace Semien is putting her body on a performance improvement plan so that she handles the Job of Life as best she can.

The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).

Columnist Marisa Zeppieri has learned that taking a rest with lupus can be necessary and shouldn't cause guilt.

When people with large public exposure talk about living with chronic illness, more people pay attention, columnist Candace Semien writes.

Lupkynis has been approved in Japan to treat lupus nephritis, when given alongside the immunosuppressant mycophenolate mofetil.